GLP-1 injections began their life as treatments for type-2 diabetes, but after incredible weight loss results were monitored in clinical trials, pharmaceutical companies sought to rebrand and get the medications approved for the treatment of obesity
This thrice-daily pill works by reducing the amount of fat your body absorbs from the foods that you eat
Therefore, the interference of regional and racial differences on the inference of risk associations cannot be ignored
Quality of bias control The randomization methods were described as adequate in 4 trials (Figure 2)
Viking Therapeutics: In November, Viking Therapeutics reported that in a small phase 1 clinical study, patients who took a daily 100mg dose of Vikings weight-loss pill lost an average of up to 6.8% of their body weight over 28 days when adjusted for those taking a placebo
Medical History: Certain conditions, such as a history of pancreatitis or specific types of thyroid tumors, may make GLP-1 medications unsuitable